Immunotherapy and Targeted Therapy Show Promise Against Melanoma In the past few years, research findings and resulting treatment improvements have more than doubled the life expectancy of patients with metastatic melanoma. Medical oncologist, Dr. Jade Homsi of Banner MD Anderson Cancer Center provides an overview of current research under way in two key areas of treatment: immunotherapy and targeted treatment. He also comments on the progress being made in research for advanced disease, including a recent breakthrough drug that is in expedited review by the FDA. Watch now. Get email alerts | Subscribe on YouTube | Like on Facebook | Follow on Twitter |